Neosalvarsan
Neosalvarsan
- Description
- Glass vial with paper label that reads in part “0.3 Gram / Lot No. / Neosalvarsan / Trade Mark Reg. U.S. Pat. Off. / BRAND OF NEOSALVARSAN / H. A. Metz Laboratories / New York, N.Y.” Neosalvarsan is a synthetic chemotherapeutic that became available in 1912 and superseded the more toxic and less water-soluble salvarsan as an effective treatment for syphilis. Both of compounds carried considerable risk of side effects, and were replaced by penicillin in the 1940s.
- Herman August Metz (1867-1934) was a New Yorker of German descent who worked for several firms that manufactured and imported German dyestuffs, chemicals, and pharmaceuticals. In 1903 he established his own firm, H. A. Metz & Co.
- Ref: “Neo-Salvarsan,” New York Times (May 20, 1912), p. 12.
- Location
- Currently not on view
- Object Name
- Pharmaceutical
- pharmaceutical
- Date made
- ca. 1927-1932
- maker
- H.A. Metz Laboratories
- place made
- United States: New York, New York City
- Measurements
- overall: 8.5 cm x 1.8 cm; 3 3/8 in x 11/16 in
- overall: 3 3/8 in x 3/4 in; 8.5725 cm x 1.905 cm
- ID Number
- 2001.0314.214
- accession number
- 2001.0314
- catalog number
- 2001.0314.214
- Credit Line
- Gift of The History Factory
- subject
- Sterling Drug Collection
- See more items in
- Medicine and Science: Medicine
- Data Source
- National Museum of American History
Our collection database is a work in progress. We may update this record based on further research and review. Learn more about our approach to sharing our collection online.
If you would like to know how you can use content on this page, see the Smithsonian's Terms of Use. If you need to request an image for publication or other use, please visit Rights and Reproductions.
Note: Comment submission is temporarily unavailable while we make improvements to the site. We apologize for the interruption. If you have a question relating to the museum's collections, please first check our Collections FAQ. If you require a personal response, please use our Contact page.